Ecor1 Capital, Llc's Net Worth

Ecor1 Capital, Llc's net worth is estimated to be at least $153,973,437.03 as of 03/29/2024. CoreStreet's estimation of Ecor1 Capital, Llc's net worth is based on their sale of stock and current holding of stock.

Ecor1 Capital, Llc is Major Shareholder at Voyager Therapeutics Inc. They have executed at least 14 trades of stock as per SEC Form 4 filings. Their most recent trade was for 110,000 units of VYGR stock on 01/11/2023. Their biggest sale was on 09/30/2021 when they sold 3,000,000 units of Corvus Pharmaceuticals Inc stock for $15,120,000.00. They typically trade 4 times per year.

Total value of insider buys:
  • $134,420,917.03
Total value of insider sells:
  • $19,552,520.00
Most recent insider trade:
  • Jan. 11, 2023

Ecor1 Capital, Llc's Insider Trading History

Voyager Therapeutics IncTitleAmountPriceTypeTotal Value
Jan. 11, 2023
Major Shareholder110,000$8.50Sell$935,000.00
Jan. 9, 2023
Major Shareholder456,000$7.67Sell$3,497,520.00
June 23, 2022
Major Shareholder376,000$5.66Buy$2,128,160.00
June 21, 2022
Major Shareholder101,400$5.28Buy$535,392.00
AnaptysBio IncTitleAmountPriceTypeTotal Value
May 5, 2022
Major Shareholder668,237$21.63Buy$14,453,966.31
April 26, 2021
Director13,900$23.80Buy$330,820.00
April 23, 2021
Director99,600$23.54Buy$2,344,584.00
March 8, 2021
Major Shareholder2,777,800$18.97Buy$52,694,866.00
Feb. 23, 2021
Major Shareholder29,500$25.48Buy$751,660.00
Prothena Corporation plcTitleAmountPriceTypeTotal Value
May 5, 2022
Major Shareholder1,062,736$29.02Buy$30,840,598.72
Jan. 12, 2022
Major Shareholder300,000$37.50Buy$11,250,000.00
March 24, 2021
Major Shareholder875,000$20.75Buy$18,156,250.00
Feb. 23, 2021
Major Shareholder44,400$21.05Buy$934,620.00
Corvus Pharmaceuticals IncTitleAmountPriceTypeTotal Value
Sept. 30, 2021
Major Shareholder3,000,000$5.04Sell$15,120,000.00